Advancing Healthcare Technology Investments

In 2019 MC closed its inaugural investment in a biotechnology business based in Cape Town, thus executing on its intention to be an investor in Healthcare technology. Hyrax Biosciences produces DNA analysis software that:

• Enables early detection of cancer

•  Informs personalised treatment for a range of diseases